Neuroscience beyond boundaries: Dr. Melissa Perreault bridges Indigenous knowledge and brain science

University of Guelph researcher pioneers sex-specific biomarkers, neuroethics, and psychedelics research in neuropsychiatry

2025-03-04

(Press-News.org) GUELPH, Ontario, Canada, 4 March 2025 – In an exclusive Genomic Press Interview, Dr. Melissa Perreault reveals how her research is reshaping neuroscience by merging cutting-edge science with Indigenous knowledge. As a professor in the Department of Biomedical Sciences at the University of Guelph and a member of the Royal Society of Canada, Dr. Perreault’s work spans neurobiology, ethical research practices, and the therapeutic potential of psychedelics—all while championing Indigenous representation in STEM.

Raised in a low-income, single-parent household, she was the first in her family to attend university. As she navigated academia, she encountered systemic barriers but persevered, ultimately becoming a leader in translational neuroscience. Today, she not only advances scientific discovery but also uplifts underrepresented voices, leading initiatives to decolonize and Indigenize neuroscience.

"We need to rethink how we conduct neuroscience. Traditional knowledge holds valuable insights that can help us better understand brain health, yet it is often overlooked in Western research," says Dr. Perreault.

Innovative Research: Biomarkers, Psychedelics, and Complexity Science

Dr. Perreault’s research program focuses on three core areas:

Sex-Specific Biomarkers in Neuropsychiatric Disorders: She is pioneering studies on depression and autism spectrum disorders, working toward precision medicine approaches that consider biological sex differences in brain function. Psychedelics and Whole-Organism Research: Her work explores the neurobiological effects of whole psilocybin mushrooms and other traditional medicines, investigating their potential in mental health treatment beyond isolated compounds. Complexity Science and Holistic Neuroscience: She advocates for moving beyond reductionist approaches, integrating environmental, social, and biological factors to develop a more complete understanding of the brain. Her work on psychedelics is particularly groundbreaking, as it challenges conventional methodologies in drug discovery. While pharmaceutical research typically isolates active compounds, Dr. Perreault emphasizes the importance of studying whole plants and fungi as they are traditionally used, recognizing the possible synergy of multiple bioactive compounds.

"People are using whole mushrooms, yet research focuses only on isolated molecules. We need to investigate how these natural compounds work together, rather than just trying to extract a ‘magic bullet’ chemical," she explains.

The Future of Ethical and Inclusive Neuroscience

Dr. Perreault’s leadership extends beyond the lab. She is actively shaping global discussions on ethical engagement with Indigenous communities in research, promoting strength-based collaborations rather than extractive scientific practices. Her leadership within the Crosscultural Working Group of the International Brain Initiative is helping build bridges between Western science and traditional knowledge.

She also advocates for a shift in how neuroscience approaches diversity—not just in study participants, but in research design itself. She calls for more inclusive methodologies that consider diverse worldviews, cultural understandings of health, and ethical community-based research partnerships.

"Science cannot remain isolated from the real-world experiences of the people it aims to help. By broadening our perspectives, we can create truly transformative discoveries," she concludes.

Professor Melissa Perreault’s Genomic Press interview is part of a larger series called Innovators & Ideas that highlights the people behind today’s most influential scientific breakthroughs. Each interview in the series offers a blend of cutting-edge research and personal reflections, providing readers with a comprehensive view of the scientists shaping the future. By combining a focus on professional achievements with personal insights, this interview style invites a richer narrative that both engages and educates readers. This format provides an ideal starting point for profiles that delve into the scientist’s impact on the field, while also touching on broader human themes. More information on the research leaders and rising stars featured in our Innovators & Ideas – Genomic Press Interview series can be found in our publication website: https://genomicpress.kglmeridian.com/.

The full Genomic Press Interview, titled ‘Melissa Perreault: Thinking big towards a “complexity science” approach in neuroscience – systems, environment, and whole organism research,’ is freely available through Open Access starting on 4 March 2025 in Genomic Psychiatry at the following hyperlink: https://doi.org/10.61373/gp025k.0011.

About Genomic Psychiatry – Genomic Psychiatry: Advancing Science from Genes to Society (ISSN: 2997-2388) represents a paradigm shift in genetics journals by interweaving advances in genomics and genetics with progress in all other areas of contemporary psychiatry. Genomic Psychiatry publishes peer-reviewed medical research articles of the highest quality from any area within the continuum that goes from genes and molecules to neuroscience, clinical psychiatry, and public health.

END

[Attachments] See images for this press release:

Neuroscience beyond boundaries: Dr. Melissa Perreault bridges Indigenous knowledge and brain science 2

Neuroscience beyond boundaries: Dr. Melissa Perreault bridges Indigenous knowledge and brain science 3

ELSE PRESS RELEASES FROM THIS DATE:

Giant clone of seaweed in the Baltic Sea

2025-03-04

Researchers at the University of Gothenburg have discovered that what was previously thought to be a unique seaweed species of bladderwrack for the Baltic Sea is in fact a giant clone of common bladderwrack, perhaps the world's largest clone overall. The discovery has implications for predicting the future of seaweed in a changing ocean. In the brakish waters of the Baltic Sea, bladderwrack is the dominant seaweed species as it is one of the few seaweed species that can tolerate low salinity. The ...

Motion capture: In world 1st, M. mobile’s motility apparatus clarified

2025-03-04

Mycoplasmas, including bacteria that cause pneumonia in humans, are generally nonmotile, but Mycoplasma mobile, as the species name suggests, has been found in the gills of fish and seems to move by gliding along surfaces. The molecular structure that allows it to do so has for the first time been uncovered by a collaborative research group led by Osaka Metropolitan University Professor Makoto Miyata of the Graduate School of Science. The OMU-led research team has been working since 1997 to clarify M. mobile’s motility mechanisms. ...

One-third of older Canadians at nutritional risk, study finds

2025-03-04

One-third of Canadian adults aged 55 or older are nutritionally at risk, potentially leading to increased hospital stays, more emergency visits and physician consultations for possible infections, a new study found. The University of Waterloo researchers assessed data from more than 22,000 community-dwelling adults aged 55 and over from the Canadian Longitudinal Study on Aging. After an initial evaluation, they followed up with participants up to three years later to track their health-service use over the previous year. Researchers used the SCREEN-8 tool (Seniors ...

Enhancing climate action: satellite insights into fossil fuel CO2 emissions

2025-03-04

Reliable and accurate monitoring of CO2 emissions is a cornerstone of effective climate change mitigation strategies. While traditional methods largely depend on ground-based measurements and bottom-up inventories, these approaches are often resource-intensive and prone to errors. Satellite Technology has emerged as a promising alternative, but the challenge remains in distinguishing anthropogenic emissions from natural processes. The long atmospheric lifetime of CO2 makes it difficult to pinpoint localized sources of emissions and track changes over time. Additionally, natural emissions and background concentrations ...

Operating a virtual teaching and research section as an open source community: Practice and experience

2025-03-04

The teaching and research section is the fundamental organizational unit for teaching and research in a university, and the virtual teaching and research section (VTRS) is a crucial exploration for the digital transformation of new basic teaching organization construction in the information age. However, this new type of organization transcends university and spatial boundaries, and motivating participants and sustaining their engagement is a key challenge in VTRS operation. The VTRS for database courses (VTRS-DB) proposes an open community-based operating model, founded on the core concepts of "openness, dedication, competition, and orderliness." ...

Lack of medical oxygen affects millions

2025-03-04

Six out of every ten people globally lack access to safe medical oxygen, resulting in hundreds of thousands of preventable deaths each year and reducing quality of life for millions more, an international report co-authored by the University of Auckland has found. Associate Professor Stephen Howie from the University’s Faculty of Medical and Health Sciences (FMHS) was an adviser to the Lancet Global Health Commission on Medical Oxygen Security and co-author of its report Reducing global inequities in medical oxygen access released 18 February. A key finding shows global access to medical oxygen is highly inequitable. Five billion ...

Business School celebrates triple crown

2025-03-04

In a crowning achievement, the University of Auckland Business School is one of the best in the world, successfully gaining triple crown accreditation - a mark of excellence held by only one percent of business schools globally.   The Business School was the first in Australasia to attain triple crown status in 2004, a recognition it has maintained for two decades. Triple crown status is achieved if a business school can meet the strict requirements of three international accreditation bodies – the Association to Advance ...

Can Rhizobium + low P increase the yield of common bean in Ethiopia?

2025-03-04

Common bean (Phaseolus vulgaris) is a leguminous plant that can form a symbiotic relationship with rhizobia in the soil. Rhizobia convert nitrogen in the atmosphere into ammonia, providing nitrogen nutrition for leguminous plants. However, due to the low effectiveness of rhizobia in the soil, common bean has one of the lowest nitrogen fixation efficiencies among food legumes. Some studies have shown that pre-inoculating common bean seeds with elite rhizobial strains can enhance nitrogen fixation, thereby promoting the plant growth of common bean and increasing the grain yield. As one of the most important food legumes in Ethiopia, the grain yield of common bean is quite low, because of the lack ...

Research Security Symposium on March 12

2025-03-04

In recent years, with the increasing openness and internationalization of research, the risks of inappropriate exploiting openness of research have become more apparent. With the growing importance of research security, the issue of how to safely promote cutting-edge research and international collaboration while respecting research freedom is becoming more important in many countries. The Japan Science and Technology Agency (JST) organizes the symposium aiming to create an opportunity to deepen discussion on efforts necessary to protect research freedom. The symposium will consist of ...

Special type of fat tissue could promote healthful longevity and help maintain exercise capacity in aging

2025-03-04

Rutgers Health researchers have made discoveries about brown fat that may open a new path to helping people stay physically fit as they age. A team from Rutgers New Jersey Medical School found that mice lacking a specific gene developed an unusually potent form of brown fat tissue that expanded lifespan and increased exercise capacity by roughly 30%. The team is working on a drug that could mimic these effects in humans. “Exercise capacity diminishes as you get older, and to have a technique ...